Rituximab in the treatment of diffuse large B-Cell lymphomas

被引:41
作者
Coiffier, B
机构
[1] Hospices Civils Lyon, Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
关键词
D O I
10.1053/sonc.2002.30153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:30 / 35
页数:6
相关论文
共 30 条
  • [11] Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma
    Grossbard, ML
    Fidias, P
    Kinsella, J
    O'Toole, J
    Lambert, JM
    Blattler, WA
    Esseltine, D
    Braman, G
    Nadler, LM
    Anderson, KC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (02) : 509 - 515
  • [12] Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Salles, G
    Coiffier, B
    Brice, P
    Bosly, A
    Morel, P
    Nouvel, C
    Tilly, H
    Lederlin, P
    Sebban, C
    Brière, J
    Gaulard, P
    Reyes, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3025 - 3030
  • [13] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997
    Harris, NL
    Jaffe, ES
    Diebold, J
    Flandrin, G
    Muller-Hermelink, HK
    Vardiman, J
    Lister, TA
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3835 - 3849
  • [14] HARRIS NL, 1994, BLOOD, V84, P1361
  • [15] Iodine-131 - Anti-B1 radioimmunotherapy for B-cell lymphoma
    Kaminski, MS
    Zasadny, KR
    Francis, IR
    Fenner, MC
    Ross, CW
    Milik, AW
    Estes, J
    Tuck, M
    Regan, D
    Fisher, S
    Glenn, SD
    Wahl, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 1974 - 1981
  • [16] MALONEY DG, 1994, BLOOD, V84, P2457
  • [17] Maloney DG, 1997, BLOOD, V90, P2188
  • [18] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program
    McLaughlin, P
    Grillo-López, AJ
    Link, BK
    Levy, R
    Czuczman, MS
    Williams, ME
    Heyman, MR
    Bence-Bruckler, I
    White, CA
    Cabanillas, F
    Jain, V
    Ho, AD
    Lister, J
    Wey, K
    Shen, D
    Dallaire, BK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2825 - 2833
  • [19] RANDOMIZED PHASE-II COMPARISON OF STANDARD CHOP WITH WEEKLY CHOP IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA
    MEYER, RM
    BROWMAN, GP
    SAMOSH, ML
    BENGER, AM
    BRYANTLUKOSIUS, D
    WILSON, WEC
    FRANK, GL
    LEBER, BF
    STERNBACH, MS
    FOSTER, GA
    SKINGLEY, P
    LEVINE, MN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2386 - 2393
  • [20] Monoclonal antibody-based therapies for hematologic malignancies
    Multani, PS
    Grossbard, ML
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3691 - 3710